Ravi Nalliah

Ravi Nalliah is a seasoned professional in the field of clinical orchestration and finance with extensive experience spanning over two decades. Currently serving as Chief Strategy Officer and Co-Founder of TrakCel Ltd. since May 2016, Ravi Nalliah focuses on ensuring efficient patient therapy delivery in regenerative and cell-based therapies. Additionally, in the role of Non-Executive Director at Emerging Therapy Solutions, Ravi Nalliah oversees the management of cell and gene therapy treatments for healthcare payers. Previously, Ravi Nalliah held significant positions including Finance Director at PCI - Packaging Coordinators Inc. and Chief Finance and Strategy Officer at Biotec Worldwide Supplies Group. Early career experiences include corporate finance management at Broomfield & Alexander and advisory board membership at Greenaway Scott. Ravi Nalliah holds a Bachelor of Science degree in Biochemistry and Molecular Biology from Cardiff University.